Methods for Distinguishing Athlete’s Heart from Structural Heart Disease, with Emphasis on Hypertrophic Cardiomyopathy

  • B. J. Maron


In young competitive athletes, the differential diagnosis between physiologic, nonpathologic changes in cardiac morphology associated with training (commonly referred to as “athlete’s heart”) [1] and certain cardiac diseases with the potential for sudden death represents an important and not uncommon clinical problem. Such crucial diagnostic distinctions often involve hypertrophic cardiomyopathy (HCM) [2], which is the most comon cause of sudden death in young competitive athletes [3].


Left Ventricular Hypertrophy Hypertrophic Cardiomyopathy Structural Heart Disease Trained Athlete Left Ventricular Wall Thickness 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Maron BJ (1986) Structural features of the athlete heart as defined by echocardiography. J Am Coll Cardiol 7:190–203PubMedCrossRefGoogle Scholar
  2. 2.
    Maron BJ, Pelliccia A, Spirito P (1995) Cardiac disease in young trained athletes: Methods for distinguishing athlete’s heart from structural heart disease with particular emphasis on hypertrophic cardiomyopathy. Circulation 92:1596–1601CrossRefGoogle Scholar
  3. 3.
    Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO (1996) Sudden death in young competitive athletes: Clinical, dermographic and pathological profiles. JAMA 276:199–204PubMedCrossRefGoogle Scholar
  4. 4.
    Maron BJ, Mitchell JH (1994) 26th Bethesda Conference. Recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol 24:845–899CrossRefGoogle Scholar
  5. 5.
    McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G, Camerini F (1994) Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J 71:215–218CrossRefGoogle Scholar
  6. 6.
    Maron BJ, Epstein SE (1979) Hypertrophic cardiomyopathy: A discussion of nomenclature. Am J Cardiol 43:1242–1244CrossRefGoogle Scholar
  7. 7.
    Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P (1991) The upper limit of physiologic cardiac hypertophy in highly trained elite athletles. N Engl J Med 324:295–301PubMedCrossRefGoogle Scholar
  8. 8.
    Maron BJ, Gottdiener JS, Epstein SE (1981) Patterns and significance of the distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A wide-angle, two-dimensional echocardiographic study of 125 patients. Am J Cardiol 48:418–428PubMedCrossRefGoogle Scholar
  9. 9.
    Klues HG, Schiffers A, Maron BJ (1995) Phenotypic spectrum and petterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observation and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 26:1699–1708PubMedCrossRefGoogle Scholar
  10. 10.
    Maron BJ, Spirito P, Wesley Y, Arce J (1985) Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med 315:610–614CrossRefGoogle Scholar
  11. 11.
    Lewis JF, Spirito P, Pelliccia A, Maron BJ (1992) Usefulness of Doppler echocardiographic assessment of diastolic filling in distinguishing “athlete’s heart” from hypertrophic cardiomyopathy. Br Heart J 68:296–300PubMedCrossRefGoogle Scholar
  12. 12.
    Lattanzi F, Spirito P, Picano E, Mazzarisi A, Landini L, Distante A, Vecchio C, Labbate A (1991) Quantitative assessment of ultrasonic myocardial reflectivity in hypertrophic cardiomyopathy. J Am Coll Cardiol 17:1085–1090PubMedCrossRefGoogle Scholar
  13. 13.
    Spirito P, Pelliccia A, Proschan MA, Granata M, Spataro A, Caselli G, Biffi A, Vecchio C, Maron BJ (1994) Morphology of the “athlete’s heart” assessed by echocardiography in 947 elite athletes representing 27 sports. Am J Cardiol 74:802–806PubMedCrossRefGoogle Scholar
  14. 14.
    Pelliccia A, Maron BJ, Spataro A, Caselli G (1993) Absence of left ventricular hypertrophy in athletes engaged in intense power training. Am J Cardiol 72:1048–1054PubMedCrossRefGoogle Scholar
  15. 15.
    Pelliccia A, Maron BJ, Culasso F, Spataro A, Caselli G (1996) Athlete’s heart in women: Echocardiographic characterization of highly trained elite female athletes. JAMA 276:211–215PubMedCrossRefGoogle Scholar
  16. 16.
    Maron BJ, Pelliccia A, Spataro A, Granata M (1993) Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes. Br Heart J 69:125–128PubMedCrossRefGoogle Scholar
  17. 17.
    Ehsani AA, Hagberg JM, Hickson RC (1978) Rapid changes in left ventricular dimension and mass in response to physical conditioning and deconditioning. Am J Cardiol 42:52–26PubMedCrossRefGoogle Scholar
  18. 18.
    Maron BJ, Nichols PF, Pickle LW, Wesley YE, Mulvihill JJ (1984) Patterns of inheritance in hypertrophic cardiomyopathy: Assessment by M-mode and two-dimensional echocardiography. Am J Cardiol 53:1087–1094PubMedCrossRefGoogle Scholar
  19. 19.
    Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna WJ, Vosberg HP, Seidman JG, Seidman CE (1994) a-Tropomyosin and cardiac troponin T mutations cause ’familial hypertrophic cardiomyopathy: A disease of the sarcomere. Cell 77:701–712PubMedCrossRefGoogle Scholar
  20. 20.
    Watkins H, Rosenzweig A, Hwang DS, Levi T, McKenna UJ, Seidman CE, Seidman JG (1992) Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 326:1108–1114PubMedCrossRefGoogle Scholar
  21. 21.
    Watkins H, Conner D, Thierfelder L, Jarcho JA, Suk HJ, McRae C, McKenna WJ, Maron BJ, Seidman JG, Seidman CE (1995) Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nature Genetics 11:434–437PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1997

Authors and Affiliations

  • B. J. Maron
    • 1
  1. 1.Cardiovascular Research DivisionMinneapolis Heart Institute FoundationMinneapolisUSA

Personalised recommendations